Related Experiment Video

Updated: Aug 7, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Evaluation of organ specificity of mutagenic

L P Sycheva1

  • 1Laboratory of Mutagenesis, A. N. Sysin Institute of Human Ecology and Environmental Hygiene, Russian Academy of Medical Sciences, Moscow. sysin@elnet.msk.ru

Bulletin of Experimental Biology and Medicine
|September 11, 2001
PubMed

Insights

Cyclophosphamide caused significant genetic damage in mouse organs, particularly the urinary bladder and bone marrow. This study highlights organ-specific mutagenicity for predicting chemical carcinogenicity.

Area of Science:

  • Toxicology
  • Genetics
  • Carcinogenesis

Background:

  • Cyclophosphamide is a widely used chemotherapeutic agent with known mutagenic and carcinogenic properties.
  • Understanding the organ-specific effects of chemical mutagens is crucial for predicting carcinogenic risks.
  • Cytogenetic assays provide a sensitive method for detecting DNA damage in vivo.

Purpose of the Study:

  • To evaluate the in vivo cytogenetic effects of cyclophosphamide across seven different mouse organs.
  • To identify the primary target organs of cyclophosphamide-induced mutagenicity.
  • To assess the utility of this multi-organ approach for predicting chemical carcinogenicity.

Main Methods:

  • Administration of cyclophosphamide to mice.
  • Cytogenetic analysis of samples from seven organs: urinary bladder, bone marrow, lungs, large intestine, stomach, liver, and kidneys.
  • Evaluation of chromosomal aberrations and other cytogenetic damage.

Main Results:

  • Cyclophosphamide induced the most pronounced cytogenetic changes in the urinary bladder and bone marrow.
  • Mutagenic effects were also observed in the lungs, large intestine, and stomach.
  • Minimal effects were noted in the liver and kidneys, suggesting organ-specific toxicity.

Conclusions:

  • The urinary bladder and bone marrow are key target organs for cyclophosphamide's mutagenic effects.
  • The multi-organ cytogenetic evaluation approach is effective for determining mutagen organ specificity.
  • This method aids in predicting the carcinogenic potential of chemical compounds based on their mutagenic activity in specific organs.

More Related Videos

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver10:38

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver

Published on: May 4, 2016

The Lambda Select cII Mutation Detection System07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).